|
Nutri Pharmaceuticals
Research Inc. (NRPR), a leading developer and marketer
of powdered nutritional ingredients, announces it has
again received renewal of its Kosher certification for
the company's O2PTM family of oil powders.
Kosher certification guarantees that both the
ingredients and manufacturing equipment used to produce
O2PTM Powders meet the stringent requirements of
"Kashrus" or Jewish dietary laws.
According to NPRI president and CEO, Godfrey Yew,
"Maintaining our Kosher certification is important for
the present and future growth of our company.
Kosher certification is further proof of our commitment
to providing the highest quality, purity and consistency
in our O2P powdered oils to the food and nutraceutical
industries."
Certification was provided by OK Kosher Certification,
whose "OK" is among the world's most respected kosher
symbols, establishing the standards for kosher in the
United States, Europe and the Orient.
Copies of the certifications are on file and available
upon request.
About NRPR:
Nutri Pharmaceuticals Research Inc. (www.o2pus.com)
provides a wide range of powdered oils for functional
food, food supplement; pharmaceutical; cosmetic; pet
food and animal feed applications.
The company is one of a select few to be awarded the
prestigious Nutrition Business Journal "Product Merit
Award" for its patent-pending O2PTM Powderization
process. At the heart of its oil powders is the O2PTM
Oil-to-Powder technology. This patent-pending process
converts most edible oils, gels or pastes into a
free-flowing powder without affecting the isomeric
structure, fatty acid profile, color, taste or aroma of
the base oil. O2PTM does not rely on traditional
techniques that utilize extremes in heat or cold,
micro-encapsulation or nanotechnology. This facilitates
food marketing and supplement producers' ability to
create functional foods and nutraceuticals by adding
anti-oxidants, specific EFAs, or other fatty acids such
as EPA, GLA, DHA, and CLA to assist in maintaining
specific health issues.
The company currently offers more than 50 shelf-stable
powders. The company can also apply O2PTM technology to
a third-party's oil, paste or gel through an arrangement
called tolling. Based in Las Vegas, the company has
representative sales offices near Chicago, Amsterdam,
Guatemala City and Bangkok.
Nutri Pharmaceuticals Research Inc. shares are currently
traded in the United States on the "Pinksheets" under
the symbol NRPR.PK.
Forward-looking statements
All statements contained in this Press Release, other
than statements of historical facts, that address future
activities, events or developments are forward-looking
statements, including, but not limited to, statements
containing the words "believe," "anticipate," "expect"
and words of similar import. These statements are based
on certain assumptions and analyses made by us in light
of our experience and our assessment of historical
trends, current conditions and expected future
developments as well as other factors we believe are
appropriate under the circumstances. However, whether
actual results will conform to the expectations and
predictions of management is subject to a number of
risks and uncertainties that may cause actual results to
differ materially.
Such risks include, among others, the following:
international, national and local general economic and
market conditions: our ability to sustain, manage or
forecast our growth; raw material costs and
availability; new product development and introduction;
existing government regulations and changes in, or the
failure to comply with, government regulations; adverse
publicity; competition; the loss of significant
customers or suppliers; fluctuations and difficulty in
forecasting operating results; changes in business
strategy or development plans; business disruptions; the
ability to attract and retain qualified personnel; the
ability to protect technology; and other factors
referenced in this and previous disclosures.
Consequently, all of the forward-looking statements made
in this Press Release are qualified by these cautionary
statements and there can be no assurance that the actual
results anticipated by management will be realized or,
even if substantially realized, that they will have the
expected results or consequences to or effects on our
business operations.
Click here to get News Releases
NPRI Reports
Record First Quarter Earnings
|